Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facility

References

• UNODC. World Drug Report 2016. United Nations Office on Drugs and Crime; 2016.
   Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50-51):1378–1382.
   PubMed Web of Science ®Google Scholar
• Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300(22):2613–2620.
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA 2015;314(14):1468–1478.
   PubMed Web of Science ®Google Scholar
• Madah-Amiri D, Clausen T, Myrmel L, Brattebo G, Lobmaier P. Circumstances surrounding non-fatal opioid overdoses attended by ambulance services. Drug Alcohol Rev. 2017;36(3):288–294.
   PubMed Web of Science ®Google Scholar
• European Drug Report 2015. European Monitoring Centre for Drugs and Drug Addiction; 2015.
   Google Scholar
• Gjersing L, Jonassen KV, Biong S, et al. Diversity in causes and characteristics of drug-induced deaths in an urban setting. Scand J Public Health. 2013;41(2):119–125.
   PubMed Web of Science ®Google Scholar
• Amundsen EJ, Bretteville-Jensen AL. Hard drug use in Norway. Nordisk Alkohol- & Narkotikatidskrift. 2010;27(1):87.
   Google Scholar
• Murthy VH. Surgeon general's report on alcohol, drugs, and health. JAMA 2017;317(2):133–134.
   PubMed Web of Science ®Google Scholar
• Murthy VH. Ending the opioid epidemic - a call to action. N Engl J Med. 2016;375(25):2413–2415.
   PubMed Web of Science ®Google Scholar
• Reports of the Surgeon General. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington (DC): US Department of Health and Human Services; 2016.
   Google Scholar
• Rhodes T, Hedrich D. Harm Reduction: Evidence, Impacts and Challenges. Spain: Publiations Office of the Europen Union; 2010.
   Google Scholar
• Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep 2017;14(5):161–183.
   PubMed Web of Science ®Google Scholar
• Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.
   PubMed Web of Science ®Google Scholar
• Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–1437.
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall MW, Li K, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126–130.
   PubMed Web of Science ®Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–318.
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Small W, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171(7):731–734.
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102(6):916–919.
   PubMed Web of Science ®Google Scholar
• DeBeck K, Kerr T, Bird L, et al. Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2-3):172–176.
   PubMed Web of Science ®Google Scholar
• Kinnard EN, Howe CJ, Kerr T, Skjodt Hass V, Marshall BD. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark. Harm Reduct J. 2014;11(1):29.
   PubMedGoogle Scholar
• Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction. 2010;105(4):676–683.
   PubMed Web of Science ®Google Scholar
• Hathaway AD, Tousaw KI. Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver. Int J Drug Policy. 2008;19(1):11–16.
   PubMed Web of Science ®Google Scholar
• Beletsky L, Davis CS, Anderson E, Burris S. The law (and politics) of safe injection facilities in the United States. Am J Public Health. 2008;98(2):231–237.
   PubMed Web of Science ®Google Scholar
• Rhodes T, Watts L, Davies S, et al. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Soc Sci Med. 2007;65(3):572–585.
   PubMed Web of Science ®Google Scholar
• Rhodes T, Kimber J, Small W, et al. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction. 2006;101(10):1384–1393.
   PubMed Web of Science ®Google Scholar
• Gjersing L, Jonassen K, Skurtveit S, Bramness J, Clausen T. Emergency service use is common in the year before death among drug users who die from an overdose. J Subst Use. 2017;22(3):331–336.
   Web of Science ®Google Scholar
• Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18_suppl_3):S829–S861.
   PubMed Web of Science ®Google Scholar
• Madah-Amiri D, Clausen T, Lobmaier P. Rapid widespread distribution of intranasal naloxone for overdose prevention. Drug Alcohol Depend. 2017;173:17–23.
   PubMed Web of Science ®Google Scholar
• Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma Scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844–854.
   PubMed Web of Science ®Google Scholar
• Milloy MJ, Kerr T, Mathias R, et al. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse. 2008;34(4):499–509.
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45.
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction. 2001;96(2):241–246.
   PubMed Web of Science ®Google Scholar
• Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Public injecting and HIV risk behaviour among street-involved youth. Drug Alcohol Depend. 2010;110(3):254–258.
   PubMed Web of Science ®Google Scholar
• Madah-Amiri D, Clausen T, Lobmaier P. Utilizing a train-the-trainer model for multi-site naloxone distribution programs. Drug Alcohol Depend. 2016;163:153–156.
   PubMed Web of Science ®Google Scholar
• Heyerdahl F, Hovda KE, Bjornaas MA, et al. Pre-hospital treatment of acute poisonings in Oslo. BMC Emerg Med. 2008;8(1),
   PubMedGoogle Scholar
• Willman MW, Liss DB, Schwarz ES, Mullins ME. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2016;55(2):81–87.
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15(3):320–324.
   PubMed Web of Science ®Google Scholar
• Kerr T, Stoltz J-A, Tyndall M, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 2006;332(7535):220–222.
   PubMed Web of Science ®Google Scholar
• Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. Int J Drug Policy. 2008;19(3):183–188.
   PubMed Web of Science ®Google Scholar